Screener
Orchestra BioMed Holdings, Inc. OBIO Q2 2026 earnings
Reported August 10, 2026 · After market close
Revenue$88.0KMiss by $49.7K
EPS-$0.38Beat by $0.01
Revenue estimate$137.7K
EPS estimate-$0.39
Next report
Nov 9, 2026 (in 2 months)Revenue estimate$128.0K
EPS estimate-$0.40
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Orchestra BioMed Holdings, Inc. report Q2 2026 earnings?
- Orchestra BioMed Holdings, Inc. (OBIO) reported Q2 2026 earnings on August 10, 2026 after market close.
- What were Orchestra BioMed Holdings, Inc.'s Q2 2026 revenue and EPS?
- Orchestra BioMed Holdings, Inc. reported revenue of $88.0K and eps of $-0.38 for Q2 2026.
- Did Orchestra BioMed Holdings, Inc. beat estimates in Q2 2026?
- Revenue missed the consensus estimate of $137.7K by $49.7K. EPS beat the consensus estimate of $-0.39 by $0.01.
- How did Orchestra BioMed Holdings, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 89.5% from $836.0K a year earlier and eps grew 24.0% from $-0.50.
- Where can I find Orchestra BioMed Holdings, Inc.'s Q2 2026 SEC filings?
- You can read the 10-Q periodic report (0001104659-26-093357) directly on SEC EDGAR. The filing index links above go to sec.gov.
